Skip to menu Skip to content Skip to footer

2025

Journal Article

Scoping review of Productivity-Adjusted Life Years (PALYs): methods, applications and policy implications

Ademi, Zanfina, Abushanab, Dina, Arvez, Maria J. Alfonso, Marquina, Clara, Vivoda, Karl, Martikainen, Janne, Lavikainen, Piia, Lloyd, Melanie and Liew, Danny (2025). Scoping review of Productivity-Adjusted Life Years (PALYs): methods, applications and policy implications. PharmacoEconomics. doi: 10.1007/s40273-025-01544-6

Scoping review of Productivity-Adjusted Life Years (PALYs): methods, applications and policy implications

2025

Journal Article

The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes

Zomer, Ella, Zhou, Jennifer, Nelson, Adam J., Sumithran, Priya, Nanayakkara, Shane, Ball, Jocasta, Kaye, David, Liew, Danny, Nicholls, Stephen J., Stub, Dion and Zoungas, Sophia (2025). The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes. European Heart Journal - Quality of Care and Clinical Outcomes, 11 (6), 857-867. doi: 10.1093/ehjqcco/qcae063

The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes

2025

Journal Article

Rethinking cardiovascular prevention: Cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK

Morton, Jedidiah I., Liew, Danny, Watts, Gerald F., Zoungas, Sophia, Nicholls, Stephen J., Dixon, Padraig and Ademi, Zanfina (2025). Rethinking cardiovascular prevention: Cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK. European Journal of Preventive Cardiology, 32 (13), 1259-1270. doi: 10.1093/eurjpc/zwaf114

Rethinking cardiovascular prevention: Cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK

2025

Journal Article

Characterizing perioperative sleep in acute renal transplants

Stretton, Brandon, Venkataraman, Karthik, Kovoor, Joshua, Gupta, Aashray, Bacchi, Stephen, Liew, Danny, Collins, Michael, Maddern, Guy and Boyd, Mark (2025). Characterizing perioperative sleep in acute renal transplants. Progress in Transplantation, 35 (3), 143-149. doi: 10.1177/15269248251349760

Characterizing perioperative sleep in acute renal transplants

2025

Journal Article

Painfully obvious? Non-operative drivers of post-operative pain and opioid exposure in a predominantly emergency surgical cohort: a multicentre observational study identifying non-operative, perioperative pain correlates

Stretton, Brandon, Booth, Andrew E. C., Kovoor, Joshua, Gupta, Aashray, Zaka, Ammar, Edwards, Suzanne, O'Callaghan, Gerry, Crawford, Gregory B., Liew, Danny, Maddern, Guy and Bacchi, Stephen (2025). Painfully obvious? Non-operative drivers of post-operative pain and opioid exposure in a predominantly emergency surgical cohort: a multicentre observational study identifying non-operative, perioperative pain correlates. Pain Practice, 25 (7) e70068, 1-11. doi: 10.1111/papr.70068

Painfully obvious? Non-operative drivers of post-operative pain and opioid exposure in a predominantly emergency surgical cohort: a multicentre observational study identifying non-operative, perioperative pain correlates

2025

Journal Article

Productivity Losses Due to Long-Term Back Problems in Working-Age Australians

Docking, Sean I., Ackerman, Ilana N., Buchbinder, Rachelle, Zomer, Ella, Liew, Danny and Ademi, Zanfina (2025). Productivity Losses Due to Long-Term Back Problems in Working-Age Australians. JAMA Network Open, 8 (8) e2527284, e2527284. doi: 10.1001/jamanetworkopen.2025.27284

Productivity Losses Due to Long-Term Back Problems in Working-Age Australians

2025

Conference Publication

LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP)

Watts, G.F., Audehm, R., Hespe, C., Liew, D., Berry, P., Chin, K.L., Rahman, M., Santani, R., Sciascia, C. and Tonkin, A. (2025). LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP). 73rd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Sydney, NSW Australia, 14-17 August 2025. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2025.06.882

LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP)

2025

Journal Article

Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study

Orman, Zhomart, Koh, Jia Wei, Trin, Caroline, Ademi, Zanfina, Zomer, Ella, Berkovic, Danielle, Ilomaki, Jenni, Bell, Simon J., Liew, Danny, Reid, Christopher M., Lybrand, Sean, Schoeninger, Brittany and Talic, Stella (2025). Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study. British Journal of Clinical Pharmacology bcp.70170. doi: 10.1002/bcp.70170

Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study

2025

Journal Article

Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups

Orman, Zhomart, Koh, Jia Wei, Trin, Caroline, Ademi, Zanfina, Zomer, Ella, Green, Sally, Berkovic, Danielle, Ilomaki, Jenni, Bell, Simon, Liew, Danny, Reid, Christopher M, Lybrand, Sean, Schoeninger, Brittany and Talic, Stella (2025). Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups. Journal of Clinical Lipidology, 19 (4), 835-843. doi: 10.1016/j.jacl.2025.06.010

Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups

2025

Journal Article

Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice

Goh, Shi Hui, Batchelor, Riley, Dinh, Diem, Brennan, Angela, Peters, Stacey, Stub, Dion, Reid, Christopher, Chan, William, Liew, Danny, Wilson, William, Lefkovits, Jeffrey and VCOR investigators (2025). Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice. Catheterization and Cardiovascular Interventions, 106 (1), 165-173. doi: 10.1002/ccd.31520

Dual antiplatelet therapy prior to percutaneous coronary intervention for acute coronary syndrome: prevalence and outcomes in contemporary practice

2025

Journal Article

A narrative review of the evidence for transcatheter aortic valve implants

Lee, Leonard, Chan, Brendan Min-Wei, Spencer, Melinda, Leung, Jovi, Liew, Danny and Kim, Hansoo (2025). A narrative review of the evidence for transcatheter aortic valve implants. Journal of Cardiovascular Development and Disease, 12 (4) 113, 1-12. doi: 10.3390/jcdd12040113

A narrative review of the evidence for transcatheter aortic valve implants

2025

Journal Article

Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data

Dunbar, Sally, Liew, Danny, Ilomaki, Jenni and Talic, Stella (2025). Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data. Australian Journal of General Practice, 54 (4), 222-228. doi: 10.31128/AJGP-02-24-7168

Overall medicine burden for people on lipid-lowering therapy: cross-sectional analysis of national pharmacy dispensing data

2025

Journal Article

Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis

Morton, Jedidiah I., Liew, Danny, Watts, Gerald F., Zoungas, Sophia, Nicholls, Stephen J., Reid, Christopher M. and Ademi, Zanfina (2025). Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis. PharmacoEconomics, 43 (3), 331-349. doi: 10.1007/s40273-024-01454-z

Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis

2025

Journal Article

Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes

Abushanab, Dina, Al-Badriyeh, Daoud, Liew, Danny and Ademi, Zanfina (2025). Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes. American Journal of Preventive Cardiology, 22 100961, 1-9. doi: 10.1016/j.ajpc.2025.100961

Unraveling the Future Productivity Burden of Cardiovascular Disease in Qatar: Investigating the Modifiable Risk Factors Control in Type 2 Diabetes

2024

Journal Article

Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

Choy, Matthew C., Li Wai Suen, Christopher F. D., Con, Danny, Boyd, Kristy, Pena, Raquel, Burrell, Kathryn, Rosella, Ourania, Proud, David, Brouwer, Richard, Gorelik, Alexandra, Liew, Danny, Connell, William R., Wright, Emily K., Taylor, Kirstin M., Pudipeddi, Aviv, Sawers, Michelle, Christensen, Britt, Ng, Watson, Begun, Jakob, Radford-Smith, Graham, Garg, Mayur, Martin, Neal, van Langenberg, Daniel R., Ding, Nik S., Beswick, Lauren, Leong, Rupert W., Sparrow, Miles P. and De Cruz, Peter (2024). Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology, 9 (11), 981-996. doi: 10.1016/s2468-1253(24)00200-0

Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial

2024

Journal Article

Emergency department patient journey prediction with machine learning (Preprint)

Kovoor, Joshua George, Carmichael, Gavin John, Stretton, Brandon, Gupta, Aashray K, Kleinig, Oliver S., Ittimani, Mana, Fabian, Jack, Tan, Sheryn, Ng, Jeng Sweng, Sateakeerthy, Shrirajh, Booth, Andrew, Beath, Alexander, Kefalianos, John, Jacob, Mathew Ollapallil, Ahmed, Sadeya, Chan, Weng Onn, Kovoor, Pramesh, Gluck, Samuel, Gilbert, Toby, Malycha, James, Reddi, Benjamin A., Padbury, Robert T., Trochsler, Markus I., Maddern, Guy J., Chew, Derek P., Zannettino, Andrew C., Liew, Danny, Beltrame, John F., O’Callaghan, Patrick G. ... Bacchi, Stephen (2024). Emergency department patient journey prediction with machine learning (Preprint). JMIR AI. doi: 10.2196/67321

Emergency department patient journey prediction with machine learning (Preprint)

2024

Journal Article

A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure

Ngu, Natalie L. Y., Saxby, Edward, Worland, Thomas, Anderson, Patricia, Stothers, Lisa, Hunter, Jo, Elford, Alexander T., Ha, Phil, Hartley, Imogen, Roberts, Andrew, Seah, Dean, Tambakis, George, Connoley, Declan, Figredo, Anita, Ratnam, Dilip, Liew, Danny, Rogers, Benjamin, Sievert, William, Bell, Sally and Le, Suong (2024). A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure. Gastro Hep Advances, 4 (2) 100567, 1-10. doi: 10.1016/j.gastha.2024.10.007

A non randomised pilot study to investigate the acceptability and feasibility of LivR Well: a multifaceted 28-day home based liver optimisation program for acute-on-chronic liver failure

2024

Journal Article

The reduction of the productivity burden of cardiovascular disease by improving the risk factor control Among Australians with type 2 diabetes: a 10-year dynamic analysis

Abushanab, Dina, Al-Badriyeh, Daoud, Marquina, Clara, Morton, Jedidiah I., Lloyd, Melanie, Zomer, Ella, Talic, Stella, Liew, Danny and Ademi, Zanfina (2024). The reduction of the productivity burden of cardiovascular disease by improving the risk factor control Among Australians with type 2 diabetes: a 10-year dynamic analysis. European Journal of Preventive Cardiology. doi: 10.1093/eurjpc/zwae292

The reduction of the productivity burden of cardiovascular disease by improving the risk factor control Among Australians with type 2 diabetes: a 10-year dynamic analysis

2024

Journal Article

SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis

Umapathysivam, Mahesh M., Morgan, Bethany, Inglis, Joshua M., Meyer, Emily, Liew, Danny, Thiruvenkatarajan, Venkatesan and Jesudason, David (2024). SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis. JAMA Network Open, 7 (3) e242744. doi: 10.1001/jamanetworkopen.2024.2744

SGLT2 inhibitor-associated ketoacidosis vs Type 1 diabetes-associated ketoacidosis

2024

Conference Publication

Digital health for myocardial infarction: research topics and trends

Pelly, Melissa, Fatehi, Farhad, Samadbeik, Mahnaz, Liew, Danny and Verdejo-Garcia, Antonio (2024). Digital health for myocardial infarction: research topics and trends. 19th World Congress on Medical and Health Informatics, Sydney, NSW, Australia, 8 - 12 July 2023. Amsterdam, Netherlands: IOS Press. doi: 10.3233/shti231001

Digital health for myocardial infarction: research topics and trends